CNS Pharmaceuticals (NASDAQ: CNSP) Presents Updated Safety Data from Ongoing Potentially Pivotal Study Evaluating Berubicin in Advance of the Pre-Planned Interim Analysis of Efﬁcacy

berubicin (RTA 744) - CNS Pharma, WPD Pharma

Nov 22, 2023